Applying molecular immunohematology discoveries to standards of practice in blood banks: Now is the time

Transfusion

Volumn 48, Issue 11, 2008, Pages 2461-2475

  Denomme, Gregory A ^b   Flegel, Willy A ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN ANTIBODY REACTION; BLOOD BANK; MEDICAL LITERATURE; MEDICAL PRACTICE; NOTE; TRANSFUSION;

ADULT; ALLERGY AND IMMUNOLOGY; BLOOD BANKS; BLOOD GROUP ANTIGENS; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; FEMALE; FORECASTING; GUIDELINE ADHERENCE; HEMATOLOGY; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PROFESSIONAL PRACTICE;

EID: 55349139320     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01855.x     Document Type: Note

References (203)

1. Landsteiner K. Über Agglutinationserscheinungen normalen menschlichen Blutes. Wien Klin Wochenschr 1901 14 : 1132 4.
2. Robertson OH. Transfusion with preserved red blood cells. BMJ 1918 1 : 691 5.
3. Fantus B. The therapy of the Cook County hospital. J Am Med Assoc 1937 109 : 128 31.
4. Oliver PL. A plea for a national blood transfusion conference. BMJ 1936 2 : 1032 3.
5. Ottenberg R, Kaliski DJ. Accidents in transfusion: their prevention by preliminary blood examination: based on an experience of one hundred twenty-eight transfusions. J Am Med Assoc 1913 61 : 2138 9.
6. Levine P, Stetson RE. An unusual case of intra-group agglutination. J Am Med Assoc 1939 113 : 126 7.
7. Landsteiner K, Wiener AS. An agglutinable factor in human blood recognized by immune sera for Rhesus blood. Proc Soc Exp Biol Med 1940 48 : 223.
8. Wiener AS, Peters HR. Hemolytic reactions following transfusions of blood of the homologous group, with three cases in which the same agglutinogen was responsible. Ann Intern Med 1940 13 : 2306 22.
9. Levine P, Vogel P, Katzin EM, Burnham L. Pathogenesis of erythroblastosis fetalis: statistical evidence. Science 1941 94 : 371 2.
10. Coombs RR, Mourant AE, Race RR. Detection of weak and "incomplete" Rh agglutinins: a new test. Lancet 1945 ii : 15 6.
11. Coombs RR, Mourant AE, Race RR. A new test for the detection of weak and "incomplete" Rh agglutinins. Br J Exp Pathol 1945 26 : 255 66.
12. Issitt PD. Applied blood group serology. Oxnard : Spectra Biologicals 1970.
13. Diamond LK, Denton RL. Rh agglutination in various media with particular reference to the value of albumin. J Lab Clin Med 1945 30 : 821.
14. Hughes-Jones NC, Polley MJ, Telford RD, Gardner B, Kleinschmidt G. Optimal conditions for detecting blood group antibodies by the antiglobulin test. Vox Sang 1964 9 : 385 95.
15. Elliot M, Bossom E, Dupuy MD, Masouredis SP. Effect of ionic strength on the serologic behavior of red cell isoantibodies. Vox Sang 1964 9 : 396 414.
16. Löw B, Messeter L. Antiglobulin test in low-ionic strength salt solution for rapid antibody screening and cross-matching. Vox Sang 1974 26 : 53 61.
17. Boudart D, Guimbretiere J. Use of modified automated polybrene test for screening IgG sensitized RBC in routine laboratory. Pathol Biol 1977 25 : 755 7.
18. Lalezari P, Jiang AF. The manual polybrene test: a simple and rapid procedure for detection of red cell antibodies. Transfusion 1980 20 : 206 11.
19. Morton JA, Pickles MM. Use of trypsin in the detection of incomplete anti-Rh antibodies. Nature 1947 159 : 779 80.
20. Kuhns WJ, Bailey A. Use of red cells modified by papain for detection of Rh antibodies. Am J Clin Pathol 1950 20 : 1067 9.
21. Makinodan T, Macris NT. The effect of ficin on the agglutination of human red blood cells. J Immunol 1955 75 : 192 6.
22. Pirofsky B, Mangum ME. Use of bromelin to demonstrate erythrocyte antibodies. Proc Soc Exp Biol Med 1959 101 : 49 52.
23. Moore HH, Conradie JD. Solid phase indirect anti-human globulin test for identification of red blood cell antibodies in human sera. Transfusion 1982 22 : 540.
24. Beck ML, Rachel JM, Sinor LT, Plapp FV. Semi automated solid phase adherence assays for pre-transfusion testing. Med Lab Sci 1984 41 : 374 81.
25. Plapp FV, Sinor LT, Rachel JM, Beck ML, Coenen WM, Bayer WL. A solid phase antibody screen. Am J Clin Pathol 1984 82 : 719.
26. Lapierre Y, Rigal D, Adam J, Josef D, Meyer F, Greber S, Drot C. The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion 1990 30 : 109 13.
27. Flegel WA, Wagner FF, Müller TH, Gassner C. Rh phenotype prediction by DNA typing and its application to practice. Transfus Med 1998 8 : 281 302.
28. Anstee DJ. Goodbye to agglutination and all that? Transfusion 2005 45 : 652 3.
29. Lüttringhaus TA, Cho D, Ryang DW, Flegel WA. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors. Transfusion 2006 46 : 2128 37.
30. Grootkerk-Tax MG, Soussan AA, de Haas M, Maaskant-van Wijk PA, van der Schoot CE. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma. Transfusion 2006 46 : 2142 8.
31. Krog GR, Clausen FB, Dziegiel MH. Quantitation of RHD by real-time polymerase chain reaction for determination of RHD zygosity and RHD mosaicism/chimerism: an evaluation of four quantitative methods. Transfusion 2007 47 : 715 22.
32. Polin H, Danzer M, Hofer K, Gassner W, Gabriel C. Effective molecular RHD typing strategy for blood donations. Transfusion 2007 47 : 1350 5.
33. Seltsam A, Gruger D, Blasczyk R. Prokaryotic versus eukaryotic recombinant Lutheran blood group protein for antibody identification. Transfusion 2007 47 : 1630 6.
34. Hosseini-Maaf B, Hellberg A, Chester MA, Olsson ML. An extensive polymerase chain reaction-allele-specific polymorphism strategy for clinical ABO blood group genotyping that avoids potential errors caused by null, subgroup, and hybrid alleles. Transfusion 2007 47 : 2110 25.
35. Finning K, Martin P, Summers J, Daniels G. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma. Transfusion 2007 47 : 2126 33.
36. Baumgarten R, van Gelder W, van Wintershoven J, Maaskant-van Wijk PA, Beckers EA. Recurrent acute hemolytic transfusion reactions by antibodies against Doa antigens, not detected by cross-matching. Transfusion 2006 46 : 244 9.
37. Kumpel BM. Are weak D RBCs really immunogenic? [letter Transfusion 2006 46 : 1061 2.
38. Westhoff CM. Molecular genotyping for RHD: what (not) to do? Transfusion 2007 47 : 1337 9.
39. Noizat-Pirenne F, Verdier M, Lejealle A, Mercadier A, Bonin P, Peltier-Pujol F, Fialaire-Legendre A, Tournamille C, Bierling P, Ansart-Pirenne H. Weak D phenotypes and transfusion safety: where do we stand in daily practice? Transfusion 2007 47 : 1616 20.
40. Noizat-Pirenne F, Tournamille C, Bierling P, Roudot-Thoraval F, Le Pennec PY, Rouger P, Ansart-Pirenne H. Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion 2006 46 : 1328 33.
41. Walker RH, Danek A, Uttner I, Offner R, Reid M, Lee S. McLeod phenotype without the McLeod syndrome. Transfusion 2007 47 : 299 305.
42. Yan L, Wu J, Zhu F, Hong X, Xu X. Molecular basis of D variants in Chinese persons. Transfusion 2007 47 : 471 7.
43. Flegel WA, Wagner FF, Chen Q, Schlanser G, Frame T, Westhoff CM, Moulds MK. The RHCE allele ceCF: the molecular basis of Crawford (RH43). Transfusion 2006 46 : 1334 42.
44. Körmöczi GF, Wagner T, Jungbauer C, Vadon M, Ahrens N, Moll W, Muhlbacher A, Ozgul-Gulce S, Kleinrath T, Kilga-Nogler S, Schonitzer D, Gassner C. Genetic diversity of KELnull and KELel: a nationwide Austrian survey. Transfusion 2007 47 : 703 14.
45. Hue-Roye K, Lomas-Francis C, Belaygorod L, Lublin DM, Barnes J, Chung A, Fung-Kee-Fung K, Kinney J, Goldman-Lavi R, Yahalom V, Poole J, Ivankovic Z, Alcantara D, Bekavac M, Cepulic BG, Velliquette RW, Mason R, Reid ME. Three new high-prevalence antigens in the Cromer blood group system. Transfusion 2007 47 : 1621 9.
46. Grootkerk-Tax MG, van Wintershoven JD, Ligthart PC, van Rhenen DJ, van der Schoot CE, Maaskant-van Wijk PA. RHD (T201R, F223V) cluster analysis in five different ethnic groups and serological characterization of a new Ethiopian variant DARE, the DIII type 6 and the RHD (F223V). Transfusion 2006 46 : 606 15.
47. Chen Q, Hustinx H, Flegel WA. The RHCE allele ceSL: the second example for D antigen expression without D-specific amino acids. Transfusion 2006 46 : 766 72.
48. Flegel WA, Eicher NI, Doescher A, Hustinx H, Gowland P, Monsouri Taleghani B, Petershofen EK, Bauerfeind U, Ernst M, von Zabern I, Schrezenmeier H, Wagner FF. In-frame triplet deletions in RHD alter the D antigen phenotype. Transfusion 2006 46 : 2156 61.
49. Le Marechal C, Guerry C, Benech C, Burlot L, Cavelier B, Porra V, Delamaire M, Ferec C, Chen JM. Identification of 12 novel RHD alleles in western France by denaturing high-performance liquid chromatography analysis. Transfusion 2007 47 : 858 63.
50. Esteban R, Montero R, Flegel WA, Wagner FF, Subirana L, Parra R, Ribera A, Nogues N. The D category VI type 4 allele is prevalent in the Spanish population. Transfusion 2006 46 : 616 23.
51. Covas DT, de Oliveira FS, Rodrigues ES, Abe-Sandes K, Silva WA Jr., Fontes, AM. Knops blood group haplotypes among distinct Brazilian populations. Transfusion 2007 47 : 147 53.
52. Cotorruelo CM, Munini GM, Garcia Borras SE, Racca LL, Biondi CS, Racca AL. The Dc(G48)e(s) haplotype is frequent among the Dce haplotypes within a white population. Transfusion 2007 47 : 486 91.
53. von Zabern I, Flegel WA. IVS5-38del4 deletion in the RHD gene does not cause a DEL phenotype: relevance for RHD alleles including DFR-3. Transfusion 2007 47 : 1552 5.
54. Yip SP, Choi PS, Lee SY, Leung KH, El Zawahri MM, Luqmani YA. ABO blood group in Kuwaitis: detailed allele frequency distribution and identification of novel alleles. Transfusion 2006 46 : 773 9.
55. Yip SP, Lai SK, Wong ML. Systematic sequence analysis of the human fucosyltransferase 2 (FUT2) gene identifies novel sequence variations and alleles. Transfusion 2007 47 : 1369 80.
56. Lee S, Debnath AK, Wu X, Scofield T, George T, Kakaiya R, Yogore MG, III., Sausais L, Yacob M, Lomas-Francis C, Reid ME. Molecular basis of two novel high-prevalence antigens in the Kell blood group system, KALT and KTIM. Transfusion 2006 46 : 1323 7.
57. Renoud KJ, Barracchini K, Byrne KM, Adams S, Pickett A, Caruccio L, Stroncek DF. KEL6 and KEL7 genotyping with sequence-specific primers. Transfusion 2006 46 : 1510 4.
58. Poole J, Warke N, Hustinx H, Taleghani BM, Martin P, Finning K, Crew VK, Green C, Bromilow I, Daniels G. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen. Transfusion 2006 46 : 1879 85.
59. Yu X, Wagner FF, Witter B, Flegel WA. Outliers in RhD membrane integration are explained by variant RH haplotypes. Transfusion 2006 46 : 1343 51.
60. Coghlan G, Moulds M, Nylen E, Zelinski T. Molecular basis of the LOCR (Rh55) antigen. Transfusion 2006 46 : 1689 92.
61. Lin M, Hou MJ, Yu LC. A novel IGnT allele responsible for the adult i phenotype. Transfusion 2006 46 : 1982 7.
62. Karamatic C, V, Mallinson G, Green C, Poole J, Uchikawa M, Tani Y, Geisen C, Oldenburg J, Daniels G. Different inactivating mutations in the LU genes of three individuals with the Lutheran-null phenotype. Transfusion 2007 47 : 492 8.
63. Richard M, Perreault J, Constanzo-Yanez J, Khalife S, St Louis M. A new DEL variant caused by exon 8 deletion. Transfusion 2007 47 : 852 7.
64. Twu YC, Hsieh CY, Yu LC. Expression of the histo-blood group B gene predominates in AB-genotype cells. Transfusion 2006 46 : 1988 96.
65. Dohmen SE, Verhagen OJ, Muit J, Ligthart PC, van der Schoot CE. The restricted use of IGHV3 superspecies genes in anti-Rh is not limited to hyperimmunized anti-D donors. Transfusion 2006 46 : 2162 8.
66. Seltsam A, Strigens S, Levene C, Yahalom V, Moulds M, Moulds JJ, Hustinx H, Weisbach V, Figueroa D, Bade-Doeding C, DeLuca DS, Blasczyk R. The molecular diversity of Sema7A, the semaphorin that carries the JMH blood group antigens. Transfusion 2007 47 : 133 46.
67. Hata Y, Kominato Y, Takizawa H. Identification and characterization of a novel antisense RNA transcribed from the opposite strand of the human blood group ABO gene. Transfusion 2007 47 : 842 51.
68. Poole J, Tilley L, Warke N, Spring FA, Overbeeke MA, van der Mark-Zoet JA, Ahrens N, Armstrong D, Williams M, Daniels G. Two missense mutations in the CD44 gene encode two new antigens of the Indian blood group system. Transfusion 2007 47 : 1306 11.
69. Westhoff C, Vege S, Yazdanbakhsh K, Wylie D, Razib M, Hue-Roye K, Halverson G, Read S, Whiteoak E, Nickle P, Maurer J, Kavitsky D, Nance S, Reid ME. A DOB allele encoding an amino acid substitution (Phe62Ser) resulting in a Dombrock null phenotype. Transfusion 2007 47 : 1356 62.
70. Zimring JC, Spitalnik SL, Roback JD, Hillyer CD. Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis. Transfusion 2007 47 : 2189 96.
71. Storry JR, Johannesson JS, Poole J, Strindberg J, Rodrigues MJ, Yahalom V, Levene C, Fujita C, Castilho L, Hustinx H, Olsson ML. Identification of six new alleles at the FUT1 and FUT2 loci in ethnically diverse individuals with Bombay and Para-Bombay phenotypes. Transfusion 2006 46 : 2149 55.
72. Sun CF, Chen DP, Tseng CP, Wang WT, Liu JP. Identification of a novel A1v-O1v hybrid allele with G829A mutation in a chimeric individual of AelBel phenotype. Transfusion 2006 46 : 780 9.
73. Li L, Yang MH, Chak KF, Lin PH, Lai CH, Lin KT, Tsai SJ, Lin KS, Chu DC. Three missense mutations, including a novel 860C>T transition, and allelic enhancement phenomenon associated with ABO blood subgroups A in Taiwan. Transfusion 2007 47 : 1014 21.
74. Hosseini-Maaf B, Letts JA, Persson M, Smart E, LePennec PY, Hustinx H, Zhao Z, Palcic MM, Evans SV, Chester MA, Olsson ML. Structural basis for red cell phenotypic changes in newly identified, naturally occurring subgroup mutants of the human blood group B glycosyltransferase. Transfusion 2007 47 : 864 75.
75. Seltsam A, das Gupta C, Bade-Doeding C, Blasczyk R. A weak blood group A phenotype caused by a translation-initiator mutation in the ABO gene. Transfusion 2006 46 : 434 40.
76. Seltsam A, Wagner FF, Gruger D, Gupta CD, Bade-Doeding C, Blasczyk R. Weak blood group B phenotypes may be caused by variations in the CCAAT-binding factor/NF-Y enhancer region of the ABO gene. Transfusion 2007 47 : 2330 5.
77. Eyler CE, Telen MJ. The Lutheran glycoprotein: a multifunctional adhesion receptor. Transfusion 2006 46 : 668 77.
78. Minon JM, Senterre JM, Schaaps JP, Foidart JM. An unusual false-positive fetal RHD typing result using DNA derived from maternal plasma from a solid organ transplant recipient. Transfusion 2006 46 : 1454 5.
79. Campbell-Lee SA, Liu J, Velliquette RW, Halverson GR, Shirey RS, Chaudhuri A, Reid ME, Ness PM, Baldwin WM. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice. Transfusion 2006 46 : 1682 8.
80. Mosebach M, Parkner A, Jakubiczka S, Wieacker P, Heim MU. Dispermic chimerism identified during blood group determination and HLA typing. Transfusion 2006 46 : 1978 81.
81. Garratty G, Reid M, Westhoff C. A workshop on molecular methods in immunohematology. Transfusion 2007 47 : 1S 100S.
82. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975 256 : 495 7.
83. Voak D, Sacks SH, Alderson T, Takei F, Lennox E, Jarvis J, Milstein C, Darnborough J. Monoclonal anti-A from a hybrid-myeloma: evaluation as a blood grouping reagent. Vox Sang 1980 39 : 134 40.
84. Tippett P, Sanger R. Observations on subdivisions of Rh antigen D. Vox Sang 1962 7 : 9 13.
85. Lacey PA, Caskey CR, Werner DJ, Moulds JJ. Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother. Transfusion 1983 23 : 91 4.
86. Ostgard P, Fevang F, Kornstad L. Anti-D in a "D positive" mother giving rise to severe haemolytic disease of the newborn. A dilemma in antenatal immunohaematological testing. Acta Paediatr Scand 1986 75 : 175 8.
87. Wissenschaftlicher Beirat der Bundesärztekammer, Paul-Ehrlich-Institut. Richtlinien zur Blutgruppenbestimmung und Bluttransfusion (Hämotherapie). Köln : Deutscher Ärzte-Verlag 1996.
88. Wagner FF, Kasulke D, Kerowgan M, Flegel WA. Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in South-Western Germany. Infusionsther Transfusionsmed 1995 22 : 285 90.
89. Jones J, Scott ML, Voak D. Monoclonal anti-D specificity and Rh D structure: criteria for selection of monoclonal anti-D reagents for routine typing of patients and donors. Transfus Med 1995 5 : 171 84.
90. Voak D, Lennox E, Sacks S, Milstein C, Darnborough J. Monoclonal anti-A and anti-B: development as cost-effective reagents. Med Lab Sci 1982 39 : 109 22.
91. Lowe AD, Green SM, Voak D, Gibson T, Lennox ES. A human-human monoclonal anti-D by direct fusion with a lymphoblastoid line. Vox Sang 1986 51 : 212 6.
92. Thompson KM, Melamed MD, Eagle K, Gorick BD, Gibson T, Holburn AM, Hughes-Jones NC. Production of human monoclonal IgG and IgM antibodies with anti-D (rhesus) specificity using heterohybridomas. Immunology 1986 58 : 157 60.
93. Messeter L, Johnson U. Monoclonal antibodies against human red blood cells and related antigens. In : Messeter L, Johnson U, editors. J. Immunogenetics. Oxford : Blackwell Scientific 1990. p. 211 357.
94. Flegel WA, Kaucher M, Schoty S, Hochgeladen E, Northoff H. Automated testing for Rhesus-antigen with monoclonal antibodies. In : Chester MA, Johnson U, Lundblad A, Löw B, Messeter L, Samuelsson B, editors. Proceedings of the Second International Workshop and Symposium on Monoclonal Antibodies against Human Red Blood Cells and Related Antigens. Lund : Symposium Secretariat 1990. p. 151.
95. Finn R, Clarke CA, Donohoe WT, McConnell RB, Sheppard PM, Lehane D, Kulke W. Experimental studies on the prevention of Rh haemolytic disease. BMJ 1961 1 : 1486 90.
96. Freda VJ, Gorman JG. Antepartum management of Rh hemolytic disease. Bull Sloane Hosp Women Columbia Presbyt Med 1962 8 : 147 58.
97. Freda VJ, Gorman JG, Pollack W. Rh factor: prevention of isoimmunization and clinical trial on mothers. Science 1966 151 : 828 30.
98. Freda VJ, Gorman JG, Pollack W. Successful prevention of experimantal Rh sensitization in man with an anti-Rh gamma2-globulin antibody preparation: a preliminary report. Transfusion 1964 4 : 26 32.
99. Woodrow JC, Clarke CA, Donohoe WT, Finn R, McConnell RB, Sheppard PM, Lehane D, Russell SH, Kulke W, Durkin CM. Prevention of Rh-haemolytic disease: a third report. BMJ 1965 1 : 279 83.
100. Pollack W, Gorman JG, Freda VJ, Ascari WQ, Allen AE, Baker WJ. Results of clinical trials of RhoGAM in women. Transfusion 1968 8 : 151 3.
101. Rodeghiero F, Schiavotto C, Castaman G, Vespignani M, Ruggeri M, Dini E. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins. Haematologica 1992 77 : 248 52.
102. Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E, Milner R, Ali K, Barnard D, Bernstein M. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994 344 : 703 7.
103. Stratton F. Some remarks on the anti-human globulin test. Vox Sang 1960 5 : 179 81.
104. Garratty G, Petz LD. The significance of red cell bound complement components in development of standards and quality assurance for the anti-complement components of antiglobulin sera. Transfusion 1976 16 : 297 306.
105. Petz LD, Garratty G. Antiglobulin sera - past, present and future. Transfusion 1978 18 : 257 68.
106. Garratty G. The significance of complement in immunohematology. Crit Rev Clin Lab Sci 1984 20 : 25 56.
107. Howard JE, Winn LC, Gottlieb CE, Grumet FC, Garratty G, Petz LD. Clinical significance of the anti-complement component of antiglobulin antisera. Transfusion 1982 22 : 269 72.
108. Moore SB. A brief history of the early years of blood transfusion at the Mayo Clinic: the first blood bank in the United States (1935). Transfus Med Rev 2005 19 : 241 5.
109. McGowan A, Tod A, Chirnside A, Green C, McColl K, Moore S, Yap PL, McClelland DB, McCann MC, Micklem LR, James K. Stability of murine monoclonal anti-A, anti-B and anti-A,B ABO grouping reagents and a multi-centre evaluation of their performance in routine use. Vox Sang 1989 56 : 122 30.
110. Plapp FV, Rachel JM. Automation in blood banking. Machines for clumping, sticking, and gelling. Am J Clin Pathol 1992 98 : S17 S21.
111. Bennett PR, Le Van Kim C, Colin Y, Warwick RM, Cherif-Zahar B, Fisk NM, Cartron JP. Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med 1993 329 : 607 10.
112. Gassner C, Schmarda A, Nussbaumer W, Schönitzer D. ABO glycosyltransferase genotyping by polymerase-chain reaction using sequence-specific primers. Blood 1996 88 : 1852 6.
113. Prager M. Molecular genetic blood group typing by the use of PCR-SSP technique. Transfusion 2007 47 : 54S 59S.
114. Siebert PD, Fukuda M. Molecular cloning of a human glycophorin B cDNA: nucleotide sequence and genomic relationship to glycophorin A. Proc Natl Acad Sci U S A 1987 84 : 6735 9.
115. Mallinson G, Soo KS, Schall TJ, Pisacka M, Anstee DJ. Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol 1995 90 : 823 9.
116. Denomme GA, Rios M, Reid ME. Molecular protocols in transfusion medicine. San Diego : Academic Press 2000.
117. Flegel WA. Blood group genotyping in Germany. Transfusion 2007 47 : 47S 53S.
118. TRAP Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997 337 : 1861 9.
119. Seftel MD, Growe GH, Petraszko T, Benny WB, Le A, Lee CY, Spinelli JJ, Sutherland HJ, Tsang P, Hogge DE. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood 2004 103 : 333 9.
120. Wallis JP, Chapman CE, Orr KE, Clark SC, Forty JR. Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion 2002 42 : 1127 34.
121. Llewelyn CA, Taylor RS, Todd AA, Stevens W, Murphy MF, Williamson LM. The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery. Transfusion 2004 44 : 489 500.
122. Cardoso MS, Koerner K, Kubanek B. Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results. Transfusion 1998 38 : 905 7.
123. Moribe T, Kaneshige T, Inoko H. Complete HLA-A DNA typing using the PCR-RFLP method combined with allele group- and sequence-specific amplification. Tissue Antigens 1997 50 : 535 45.
124. Brooks JP. Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products. Transfusion 2005 45 : 159S 171S.
125. Blajchman MA. Bacterial contamination and proliferation during the storage of cellular blood products. Vox Sang 1998 74 : 155 9.
126. Klein HG, Anderson D, Bernardi MJ, Cable R, Carey W, Hoch JS, Robitaille N, Sivilotti ML, Smaill F. Pathogen inactivation: making decisions about new technologies. Report of a consensus conference. Transfusion 2007 47 : 2338 47.
127. Silva MA, Gregory KR, Carr-Greer MA, Holmberg JA, Kuehnert MJ, Brecher ME. Summary of the AABB interorganizational task force on bacterial contamination of platelets: fall 2004 impact survey. Transfusion 2006 46 : 636 41.
128. Mohr H, Bayer A, Gravemann U, Muller TH. Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates. Transfusion 2006 46 : 949 55.
129. Smith DB, Stowell CP, Harris NL. Case records of the Massachusetts General Hospital. Case 42-1993 - jaundice and anemia two weeks after an aortic valvuloplasty in a 62-year-old woman with splenomegaly. N Engl J Med 1993 329 : 1254 61.
130. Heddle NM, Soutar RL, O'Hoski PL, Singer J, McBride JA, Ali MA, Kelton JG. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 1995 91 : 1000 5.
131. Pineda AA, Vamvakas EC, Gorden LD, Winters JL, Moore SB. Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions. Transfusion 1999 39 : 1097 103.
132. Vamvakas EC, Pineda AA, Reisner R, Santrach PJ, Moore SB. The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis. Transfusion 1995 35 : 26 32.
133. Honig CL, Bove JR. Transfusion-associated fatalities: review of bureau of biologics reports 1976-1978. Transfusion 1980 20 : 653 61.
134. Ness PM, Shirey RS, Thoman SK, Buck SA. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion 1990 30 : 688 93.
135. Pinkerton PH, Coovadia AS, Goldstein J. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching. Transfusion 1992 32 : 814 7.
136. Salama A, Mueller-Eckhardt C. Delayed hemolytic transfusion reactions; evidence for complement activation involving allogeneic and autologous red cells. Transfusion 1984 24 : 188 93.
137. Daniels GL, Flegel WA, Fletcher A, Garratty G, Levene C, Lomas-Francis C, Moulds JJ, Moulds JM, Olsson ML, Overbeeke MA, Poole J, Reid ME, Rouger P, van der Schoot CE, Scott M, Sistonen P, Smart E, Storry JR, Tani Y, Yu L-C, Wendel S, Westhoff CM, Zelinski T. International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Cape Town report. Vox Sang 2007 92 : 250 3.
138. Beiboer SH, Wieringa-Jelsma T, Maaskant-van Wijk PA, van der Schoot CE, van Zwieten R, Roos D, den Dunnen JT, de Haas M. Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization. Transfusion 2005 45 : 667 79.
139. Denomme GA, Van Oene M. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005 45 : 660 6.
140. Bugert P, McBride S, Smith G, Dugrillon A, Klüter H, Ouwehand WH, Metcalfe P. Microarray-based genotyping for blood groups: comparison of gene array and 5′-nuclease assay techniques with human platelet antigen as a model. Transfusion 2005 45 : 654 9.
141. Hashmi G, Shariff T, Seul M, Vissavajjhala P, Hue-Roye K, Charles-Pierre D, Lomas-Francis C, Chaudhuri A, Reid ME. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005 45 : 680 8.
142. Montpetit A, Phillips MS, Mongrain I, Lemieux R, St Louis M. High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens. Transfusion 2006 46 : 841 8.
143. Avent ND, Martinez A, Flegel WA, Olsson ML, Scott ML, Nogues N, Pisacka M, Daniels GL, van der Schoot E, Muniz-Diaz E, Madgett TE, Storry JR, Beiboer SH, Maaskant-van Wijk PA, von Zabern I, Hacker A, Jimenez E, Tejedor D, Lopez M, Chamacho E, Cheroutre G, Hacker A, Jinoch P, Svobodova I, de Haas M. The BloodGen project: toward mass scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion 2007 47 : 40S 46S.
144. Hashmi G. Red blood cell antigen phenotype by DNA analysis. Transfusion 2007 47 : 60S 63S.
145. Denomme GA, Dake LR, Vilensky D, Ramyar L, Judd WJ. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques. Transfusion 2008 48 : 473 8.
146. Petrik J. Microarray technology: the future of blood testing? Vox Sang 2001 80 : 1 11.
147. van der Schoot CE, Tax GH, Rijnders RJ, de Haas M, Christiaens GC. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 2003 17 : 31 44.
148. Reid ME. Applications of DNA-based assays in blood group antigen and antibody identification. Transfusion 2003 43 : 1748 57.
149. Flegel WA. Homing in on D antigen immunogenicity. Transfusion 2005 45 : 466 8.
150. Avent ND. High variability of the RH locus in different ethnic backgrounds. Transfusion 2005 45 : 293 4.
151. Schmidt PJ, Greenwalt TJ. Hints to blood groupers, 1950. Transfusion 2006 46 : 448 53.
152. Hillyer CD, Shaz BH, Winkler AM, Reid M. Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev 2008 22 : 117 32.
153. Le Van Kim C, Mouro I, Cherif-Zahar B, Raynal V, Cherrier C, Cartron JP, Colin Y. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc Natl Acad Sci U S A 1992 89 : 10925 9.
154. Wolter LC, Hyland CA, Saul A. Rhesus D genotyping using polymerase chain reaction. Blood 1993 82 : 1682 3.
155. van den Veyver IB, Chong SS, Cota J, Bennett PR, Fisk NM, Handyside AH, Cartron JP, Le Van Kim C, Colin Y, Snabes MC. Single-cell analysis of the RhD blood type for use in preimplantation diagnosis in the prevention of severe hemolytic disease of the newborn. Am J Obstet Gynecol 1995 172 : 533 40.
156. Denomme GA, Fernandes BJ. Fetal blood group genotyping. Transfusion 2007 47 : 64S 68S.
157. Minon JM, Gerard C, Senterre JM, Schaaps JP, Foidart JM. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium. Transfusion 2008 48 : 373 81.
158. Bellissimo DB. Practice guidelines and proficiency testing for molecular assays. Transfusion 2007 47 : 79S 84S.
159. Heddle NM, O'Hoski P, Singer J, McBride JA, Ali MA, Kelton JG. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. Br J Haematol 1992 81 : 579 84.
160. Garratty G, Petz LD. Approaches to selecting blood for transfusion to patients with autoimmune hemolytic anemia. Transfusion 2002 42 : 1390 2.
161. Legler TJ, Eber SW, Lakomek M, Lynen R, Maas JH, Pekrun A, Repas-Humpe M, Schröter W, Köhler M. Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients. Transfusion 1999 39 : 852 5.
162. Reid ME, Rios M, Powell VI, Charles-Pierre D, Malavade V. DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion 2000 40 : 48 53.
163. Flegel WA, Wagner FF. Molecular biology of partial D and weak D: implications for blood bank practice. Clin Lab 2002 48 : 53 8.
164. Gubin AN, Njoroge JM, Wojda U, Pack SD, Rios M, Reid ME, Miller JL. Identification of the Dombrock blood group glycoprotein as a polymorphic member of the ADP-ribosyltransferase gene family. Blood 2000 96 : 2621 7.
165. Wagner FF, Poole J, Flegel WA. Scianna antigens including Rd are expressed by ERMAP. Blood 2003 101 : 752 7.
166. Storry JR, Olsson ML, Reid ME. Application of DNA analysis to the quality assurance of reagent red blood cells. Transfusion 2007 47 : 73S 78S.
167. Wagner FF, Flegel WA. RHD gene deletion occurred in the Rhesus box. Blood 2000 95 : 3662 8.
168. Matheson KA, Denomme GA. Novel 3′ Rhesus box sequences confound RHD zygosity assignment. Transfusion 2002 42 : 645 50.
169. Perco P, Shao CP, Mayr WR, Panzer S, Legler TJ. Testing for the D zygosity with three different methods revealed altered Rhesus boxes and a new weak D type. Transfusion 2003 43 : 335 9.
170. Wagner FF, Moulds JM, Flegel WA. Genetic mechanisms of Rhesus box variation. Transfusion 2005 45 : 338 44.
171. Kochman SA. Role of the Food and Drug Administration in the use of molecular techniques in immunohematology. Transfusion 2007 47 : 3S 9S.
172. Karpasitou K, Drago F, Crespiatico L, Paccapelo C, Truglio F, Frison S, Scalamogna M, Poli F. Blood group genotyping for Jk(a)/Jk(b), Fy(a)/Fy(b), S/s, K/k, Kp(a)/Kp(b), Js(a)/Js(b), Co(a)/Co(b), and Lu(a)/Lu(b) with microarray beads. Transfusion 2008 48 : 505 12.
173. Richard M, Perreault J, Gane P, El Nemer W, Cartron JP, St Louis M. Phage-derived monoclonal anti-Lu. Transfusion 2006 46 : 1011 7.
174. Avent ND. Recombinant technology in transfusion medicine. Curr Pharm Biotechnol 2000 1 : 117 35.
175. Kumpel BM. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis [editorial Transfusion 2006 46 : 1271 5.
176. Bauer MP, Wiersum-Osselton J, Schipperus M, Vandenbroucke JP, Briet E. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007 47 : 2066 71.
177. Branch DR, Shabani F, Lund N, Denomme GA. Antenatal administration of Rh-immune globulin causes significant increases in the immunomodulatory cytokines transforming growth factor-beta and prostaglandin E2. Transfusion 2006 46 : 1316 22.
178. Hendrickson JE, Desmarets M, Deshpande SS, Chadwick TE, Hillyer CD, Roback JD, Zimring JC. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006 46 : 1526 36.
179. Urbaniak SJ. Noninvasive approaches to the management of RhD hemolytic disease of the fetus and newborn. Transfusion 2008 48 : 2 5.
180. Westhoff CM. Deciphering the function of the Rh family of proteins. Transfusion 2005 45 : 117S 121S.
181. Howard H, Martlew V, McFadyen I, Clarke C, Duguid J, Bromilow I, Eggington J. Consequences for fetus and neonate of maternal red cell allo-immunisation. Arch Dis Child Fetal Neonatal Ed 1998 78 : F62 F66.
182. Filbey D, Hanson U, Wesstrom G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden. Acta Obstet Gynecol Scand 1995 74 : 687 92.
183. Filbey D, Berseus O, Carlberg M. Occurrence of anti-D in RhD-positive mothers and the outcome of the newborns. Acta Obstet Gynecol Scand 1996 75 : 585 7.
184. Cheong YC, Goodrick J, Kyle PM, Soothill P. Management of anti-Rhesus-D antibodies in pregnancy: a review from 1994 to 1998. Fetal Diagn Ther 2001 16 : 294 8.
185. Frohn C, Dumbgen L, Brand J-M, Gorg S, Luhm J, Kirchner H. Probability of anti-D development in D- patients receiving D+ RBCs. Transfusion 2003 43 : 893 8.
186. Yazer MH, Triulzi DJ. Detection of anti-D in D- recipients transfused with D+ red blood cells. Transfusion 2007 47 : 2197 201.
187. Lo YM, Patel P, Sampietro M, Gillmer MD, Fleming KA, Wainscoat JS. Detection of single-copy fetal DNA sequence from maternal blood. Lancet 1990 335 : 1463 4.
188. Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008 336 : 816 8.
189. Kumar S. Universal RHD genotyping in fetuses. BMJ 2008 336 : 783 4.
190. Glynn SA, Kleinman SH, Schreiber GB, Zuck T, Combs SM, Bethel J, Garratty G, Williams AE. Motivations to donate blood: demographic comparisons. Transfusion 2002 42 : 216 25.
191. Hupfer ME, Taylor DW, Letwin JA. Understanding Canadian student motivations and beliefs about giving blood. Transfusion 2005 45 : 149 61.
192. Goldman M. Blood donor selection and donation collection at Canadian Blood Services. Transfus Today 2007 72 : 21 2.
193. Reich P, Roberts P, Laabs N, Chinn A, McEvoy P, Hirschler N, Murphy EL. A randomized trial of blood donor recruitment strategies. Transfusion 2006 46 : 1090 6.
194. Preston GM, Agre P. Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family. Proc Natl Acad Sci U S A 1991 88 : 11110 4.
195. Zimring JC, Hair GA, Chadwick TE, Deshpande SS, Anderson KM, Hillyer CD, Roback JD. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 2005 106 : 1105 12.
196. Kumpel BM. On the mechanism of tolerance to the Rh D antigen mediated by passive anti-D (Rh D prophylaxis). Immunol Lett 2002 82 : 67 73.
197. Avent ND, Madgett TE, Lee ZE, Head DJ, Maddocks DG, Skinner LH. Molecular biology of Rh proteins and relevance to molecular medicine. Expert Rev Mol Med 2006 8 : 1 20.
198. Westhoff CM. Rh complexities: serology and DNA genotyping. Transfusion 2007 47 : 17S 22S.
199. Westhoff CM. The structure and function of the Rh antigen complex. Semin Hematol 2007 44 : 42 50.
200. Zarbock A, Schmolke M, Bockhorn SG, Scharte M, Buschmann K, Ley K, Singbartl K. The Duffy antigen receptor for chemokines in acute renal failure: a facilitator of renal chemokine presentation. Crit Care Med 2007 35 : 2156 63.
201. Rowe JA, Handel IG, Thera MA, Deans AM, Lyke KE, Kone A, Diallo DA, Raza A, Kai O, Marsh K, Plowe CV, Doumbo OK, Moulds JM. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proc Natl Acad Sci U S A 2007 104 : 17471 6.
202. Tournamille C, Le Van Kim C, Gane P, Le Pennec PY, Roubinet F, Babinet J, Cartron JP, Colin Y. Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood 1998 92 : 2147 56.
203. Murphy MT, Templeton LJ, Fleming J, Ferguson M, Peterkin M, Fraser RH. Comparison of Fy(b) status as determined serologically and genetically. Transfus Med 1997 7 : 135 41.